AU2001270070A1 - Nitrosated and nitrosylated taxanes, compositions and methods of use - Google Patents
Nitrosated and nitrosylated taxanes, compositions and methods of useInfo
- Publication number
- AU2001270070A1 AU2001270070A1 AU2001270070A AU2001270070A AU2001270070A1 AU 2001270070 A1 AU2001270070 A1 AU 2001270070A1 AU 2001270070 A AU2001270070 A AU 2001270070A AU 2001270070 A AU2001270070 A AU 2001270070A AU 2001270070 A1 AU2001270070 A1 AU 2001270070A1
- Authority
- AU
- Australia
- Prior art keywords
- nitrosated
- compositions
- methods
- nitrosylated taxanes
- nitrosylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940045698 antineoplastic Taxanes Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21329400P | 2000-06-22 | 2000-06-22 | |
| US60/213,294 | 2000-06-22 | ||
| US22609000P | 2000-08-18 | 2000-08-18 | |
| US60/226,090 | 2000-08-18 | ||
| PCT/US2001/019939 WO2001098286A1 (en) | 2000-06-22 | 2001-06-22 | Nitrosated and nitrosylated taxanes, compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001270070A1 true AU2001270070A1 (en) | 2002-03-21 |
| AU2001270070B2 AU2001270070B2 (en) | 2006-03-16 |
Family
ID=26907932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU7007001A Pending AU7007001A (en) | 2000-06-22 | 2001-06-22 | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| AU2001270070A Ceased AU2001270070B2 (en) | 2000-06-22 | 2001-06-22 | Nitrosated and nitrosylated taxanes, compositions and methods of use |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU7007001A Pending AU7007001A (en) | 2000-06-22 | 2001-06-22 | Nitrosated and nitrosylated taxanes, compositions and methods of use |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6656966B2 (en) |
| EP (1) | EP1301500B1 (en) |
| JP (1) | JP2004501143A (en) |
| AU (2) | AU7007001A (en) |
| CA (1) | CA2410632A1 (en) |
| DE (1) | DE60131537T2 (en) |
| WO (1) | WO2001098286A1 (en) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1118325E (en) * | 1993-07-29 | 2006-05-31 | Us Health | USES OF PACLITAXEL AND ITS DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF RESTENOSE |
| US20030040790A1 (en) | 1998-04-15 | 2003-02-27 | Furst Joseph G. | Stent coating |
| US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
| US8070796B2 (en) | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
| US7678391B2 (en) * | 2000-04-26 | 2010-03-16 | Queen's University At Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| US20050142217A1 (en) * | 2000-04-26 | 2005-06-30 | Adams Michael A. | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| AU5022101A (en) | 2000-04-26 | 2001-11-07 | Univ Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cellphenotype |
| CA2424029C (en) † | 2000-09-29 | 2008-01-29 | Cordis Corporation | Coated medical devices |
| US6627602B2 (en) * | 2001-11-13 | 2003-09-30 | Duke University | Preventing desensitization of receptors |
| US20040110691A1 (en) * | 2001-11-13 | 2004-06-10 | Stamler Jonathan S. | Thiol reactive agents as a therapeutic modality |
| AU2006252204B2 (en) * | 2001-12-06 | 2010-07-08 | Duke University | Prevention of Flap Necrosis in Plastic Surgery |
| AU2002254931A1 (en) * | 2002-03-07 | 2003-09-16 | Universite Catholique De Louvain | Method for diagnosing and treating predisposition for accelerated autosomal dominant polycystic kidney disease |
| CA2480832A1 (en) * | 2002-04-05 | 2003-10-23 | Nitromed, Inc. | Nitric oxide donors, compositions and methods of use |
| EP1496951B1 (en) | 2002-04-24 | 2006-06-14 | Insense Limited | Wound dressings comprising an oxidoreductase enzyme in hydrated condition |
| US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US8016881B2 (en) | 2002-07-31 | 2011-09-13 | Icon Interventional Systems, Inc. | Sutures and surgical staples for anastamoses, wound closures, and surgical closures |
| US6936639B2 (en) * | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| KR20120104412A (en) | 2002-09-06 | 2012-09-20 | 인설트 테라페틱스, 인코퍼레이티드 | Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| US20050009931A1 (en) * | 2003-03-20 | 2005-01-13 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| US20050004098A1 (en) * | 2003-03-20 | 2005-01-06 | Britten Nancy Jean | Dispersible formulation of an anti-inflammatory agent |
| US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| RU2325189C2 (en) * | 2003-03-20 | 2008-05-27 | Фармация Корпорейшн | Method and pharmaceutical composition for antiphlogistic agent delivery |
| ITMI20030743A1 (en) * | 2003-04-11 | 2004-10-12 | Biopeg Ltd | POLYETHYLENGLYCULATED DERIVATIVES THAT RELEASE NITRIC OXIDE. |
| US7972616B2 (en) * | 2003-04-17 | 2011-07-05 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
| US20050038498A1 (en) * | 2003-04-17 | 2005-02-17 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
| US7803574B2 (en) * | 2003-05-05 | 2010-09-28 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
| GB0313217D0 (en) | 2003-06-09 | 2003-07-16 | Insense Ltd | Improvements in or relating to skin dressings |
| EP1668008A4 (en) * | 2003-08-28 | 2009-02-25 | Nitromed Inc | Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| MXPA06007378A (en) * | 2003-12-23 | 2007-01-26 | Musc Found For Res Dev | Methods and compositions for the prevention and treatment of inflammatory diseases or conditions. |
| US7211108B2 (en) | 2004-01-23 | 2007-05-01 | Icon Medical Corp. | Vascular grafts with amphiphilic block copolymer coatings |
| WO2005114194A1 (en) * | 2004-05-21 | 2005-12-01 | Mds Inc. Doing Business Through Its Mds Pharma Services Division | Method of quantifying the cell-binding properties of a medical device |
| ATE493973T1 (en) | 2004-06-04 | 2011-01-15 | Teva Pharma | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN |
| US20060039950A1 (en) * | 2004-08-23 | 2006-02-23 | Zhengrong Zhou | Multi-functional biocompatible coatings for intravascular devices |
| WO2006024491A1 (en) * | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Methods and compositions for the treatment of cell proliferation |
| US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
| US7540995B2 (en) | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
| WO2006110197A2 (en) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
| US20060222592A1 (en) * | 2005-04-05 | 2006-10-05 | Clemens Burda | Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications |
| US20090298795A1 (en) * | 2005-06-23 | 2009-12-03 | The Johns Hopins University | Thiol-Sensitive Positive Inotropes |
| WO2007005758A2 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Methods , compositions and devices for promoting angiogenesis |
| CN101252880A (en) * | 2005-09-02 | 2008-08-27 | 宝洁公司 | Methods for retail measurement of skin moisture content |
| US7566308B2 (en) * | 2005-10-13 | 2009-07-28 | Cardiac Pacemakers, Inc. | Method and apparatus for pulmonary artery pressure signal isolation |
| WO2007058190A1 (en) * | 2005-11-16 | 2007-05-24 | Tokai University Educational System | Controlled drug release composition and drug releasing medical device |
| US20080051702A1 (en) * | 2006-08-24 | 2008-02-28 | Herrmann Robert A | Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices |
| WO2008086490A2 (en) * | 2007-01-11 | 2008-07-17 | Robert Lamar Bjork, Jr | Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention |
| US9339593B2 (en) * | 2007-01-11 | 2016-05-17 | Robert L. Bjork, JR. | Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives |
| JP2010516625A (en) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス， インコーポレイテッド | Polymer-drug conjugates with tether groups for controlled drug delivery |
| KR100904207B1 (en) | 2007-06-01 | 2009-06-25 | (주) 태웅메디칼 | Coating agent for drug releasing stent, manufacturing method thereof and drug releasing stent coated with the coating agent |
| WO2009036368A2 (en) | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
| US8319002B2 (en) * | 2007-12-06 | 2012-11-27 | Nanosys, Inc. | Nanostructure-enhanced platelet binding and hemostatic structures |
| US8304595B2 (en) | 2007-12-06 | 2012-11-06 | Nanosys, Inc. | Resorbable nanoenhanced hemostatic structures and bandage materials |
| WO2010005687A1 (en) * | 2008-06-12 | 2010-01-14 | University Of Alabama Huntsville | Compositions comprising nitric oxide or nitric oxide donors for the treatment of neurodegenerative diseases or trauma |
| EP2320728A4 (en) * | 2008-07-21 | 2013-03-13 | Osiris Therapeutics Inc | Taxane compounds for treating eye disease |
| US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
| US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
| US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
| US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
| AU2010249558A1 (en) * | 2009-05-20 | 2011-12-08 | Arsenal Medical, Inc. | Medical implant |
| US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
| US8372133B2 (en) | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
| US20110160200A1 (en) * | 2009-11-23 | 2011-06-30 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension |
| EP2509942A2 (en) * | 2009-12-07 | 2012-10-17 | Johns Hopkins University | Bis-acylated hydroxylamine derivatives |
| MX2012006349A (en) * | 2009-12-07 | 2012-10-03 | Cardioxyl Pharmaceuticals Inc | N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives. |
| WO2011082164A1 (en) | 2009-12-28 | 2011-07-07 | Colorado State University Research Foundation | Modular biocompatible materials for medical devices and uses thereof |
| US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
| US9034355B2 (en) | 2011-02-24 | 2015-05-19 | Colorado State University Research Foundation | Materials for modulating biological responses and methods of making |
| JP2015505557A (en) * | 2012-01-31 | 2015-02-23 | セルリアン・ファーマ・インコーポレイテッド | Polymers based on cyclodextrins for therapeutic delivery |
| WO2014046671A1 (en) * | 2012-09-21 | 2014-03-27 | Michigan Technological University | No-releasing polymers and uses thereof |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| BR112016030273A8 (en) | 2014-06-24 | 2021-05-18 | Icon Medical Corp | medical device and method of forming said device |
| BR112018005200A2 (en) | 2015-09-16 | 2018-10-09 | Dfb Soria Llc | release of drug nanoparticles and methods of using them |
| WO2017151548A1 (en) | 2016-03-04 | 2017-09-08 | Mirus Llc | Stent device for spinal fusion |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| CN110636833A (en) | 2017-03-15 | 2019-12-31 | Dfb索里亚有限责任公司 | Topical therapy using taxane nanoparticles for the treatment of skin malignancies |
| US11883807B2 (en) | 2017-04-11 | 2024-01-30 | Colorado State University Research Foundation | Functionalization of metal-organic frameworks |
| WO2019178024A1 (en) | 2018-03-16 | 2019-09-19 | Dfb Soria, Llc | Topical therapy for the treatment of cervical intraepithelial neoplasia (cin) and cervical cancer using nanoparticles of taxanes |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666884A (en) | 1984-04-10 | 1987-05-19 | New England Deaconess Hospital | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls |
| US4885173A (en) | 1985-05-01 | 1989-12-05 | University Of Utah | Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities |
| US5157049A (en) | 1988-03-07 | 1992-10-20 | The United States Of America As Represented By The Department Of Health & Human Services | Method of treating cancers sensitive to treatment with water soluble derivatives of taxol |
| US4900719A (en) | 1988-08-05 | 1990-02-13 | The Ohio State University | Nitrosothiols as hypotensive agents |
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| CA2081896A1 (en) | 1990-06-15 | 1991-12-16 | James E. Shapland | Drug delivery apparatus and method |
| US6028205A (en) | 1991-09-23 | 2000-02-22 | Florida State University | C2 tricyclic taxanes |
| US5284865A (en) | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
| US5399726A (en) | 1993-01-29 | 1995-03-21 | Florida State University | Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups |
| US5998656A (en) | 1991-09-23 | 1999-12-07 | Florida State University | C10 tricyclic taxanes |
| US5990325A (en) | 1993-03-05 | 1999-11-23 | Florida State University | Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5407816A (en) | 1992-02-20 | 1995-04-18 | Phyton Catalytic, Inc. | Enhanced production of taxol and taxanes by cell cultures of taxus species |
| US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| FR2698871B1 (en) | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | New taxoids, their preparation and the pharmaceutical compositions containing them. |
| US5646176A (en) | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
| IL108316A (en) | 1993-01-15 | 2006-10-31 | Univ Florida State | C10 taxane derivatives and pharmaceutical compositions containing them |
| US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| EP1260507A1 (en) | 1993-02-05 | 2002-11-27 | Bryn Mawr College | Synthesis of taxol, analogs and intermediates with variable A-nng side chains |
| US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| US5945452A (en) | 1993-06-11 | 1999-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| US5861168A (en) | 1993-06-11 | 1999-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| DK0982301T3 (en) | 1993-06-11 | 2003-12-08 | Upjohn Co | Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
| US5428070A (en) | 1993-06-11 | 1995-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity |
| US5852058A (en) | 1993-06-11 | 1998-12-22 | The Board Of Trustees Of The Leland Stanford Junior University | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
| PT1118325E (en) * | 1993-07-29 | 2006-05-31 | Us Health | USES OF PACLITAXEL AND ITS DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF RESTENOSE |
| CA2129288C (en) | 1993-08-17 | 2000-05-16 | Jerzy Golik | Phosphonooxymethyl esters of taxane derivatives |
| IL127598A (en) | 1994-01-28 | 2003-04-10 | Upjohn Co | Process for preparing isotaxol analogs |
| US5482925A (en) | 1994-03-17 | 1996-01-09 | Comedicus Incorporated | Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| MX9700026A (en) | 1994-06-28 | 1997-04-30 | Upjohn Co | 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them. |
| US5629433A (en) | 1994-07-18 | 1997-05-13 | Hauser, Inc. | Selective process for the deacylation and deacetylation of taxol and taxanes |
| WO1996011008A1 (en) | 1994-10-06 | 1996-04-18 | New York University | Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
| US6100411A (en) | 1994-10-28 | 2000-08-08 | The Research Foundation Of State University Of New York | Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| EP0738265A1 (en) | 1994-11-04 | 1996-10-23 | PHARMACIA S.p.A. | Taxane derivatives |
| GB9423868D0 (en) | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
| CA2206119C (en) | 1994-12-12 | 2008-05-13 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| US5679807A (en) | 1995-01-30 | 1997-10-21 | Hauser, Inc. | Preparation of taxol and docetaxel through primary amines |
| US6063407A (en) | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
| US5665077A (en) | 1995-04-24 | 1997-09-09 | Nitrosci Pharmaceuticals Llc | Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis |
| US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
| AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
| KR100401220B1 (en) | 1995-09-12 | 2004-03-20 | 더 리포좀 컴퍼니, 인코퍼레이티드 | Hydrophobic taxane derivatives that promote hydrolysis |
| CA2231837A1 (en) * | 1995-09-13 | 1997-03-20 | Florida State University | Radiosensitizing taxanes and their pharmaceutical preparations |
| US6177456B1 (en) | 1995-10-02 | 2001-01-23 | Xechem International, Inc. | Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor |
| WO1997019938A1 (en) | 1995-11-29 | 1997-06-05 | Consejo Superior Investigaciones Cientificas | Fluorescent derivatives of paclitaxel and docetaxel with antineoplastic activity, method for producing them and their applications |
| US5760072A (en) | 1995-12-29 | 1998-06-02 | Pharmachemie B.V. | Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| US5951458A (en) | 1996-02-29 | 1999-09-14 | Scimed Life Systems, Inc. | Local application of oxidizing agents to prevent restenosis |
| US5688977A (en) | 1996-02-29 | 1997-11-18 | Napro Biotherapeutics, Inc. | Method for docetaxel synthesis |
| US6441025B2 (en) | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
| NZ332234A (en) | 1996-03-12 | 2000-06-23 | Pg Txl Company Lp | Water soluble paclitaxel prodrugs formed by conjugating paclitaxel or docetaxel with a polyglutamic acid polymer and use for treating cancer |
| WO1997044026A1 (en) * | 1996-05-22 | 1997-11-27 | Neuromedica, Inc. | Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere |
| US5919815A (en) | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| AU3572397A (en) | 1996-07-02 | 1998-01-21 | Bristol-Myers Squibb Company | Ortho-ester analogs of paclitaxel |
| US5797887A (en) | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
| IT1295694B1 (en) | 1996-11-14 | 1999-05-27 | Nicox Sa | NITROXIS DERIVATIVES FOR THE PREPARATION OF MEDICATIONS WITH ANTI-THROMBINIC ACTIVITY |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
| US5902822A (en) | 1997-02-28 | 1999-05-11 | Bristol-Myers Squibb Company | 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| US6017935A (en) | 1997-04-24 | 2000-01-25 | Bristol-Myers Squibb Company | 7-sulfur substituted paclitaxels |
| DE19718339A1 (en) | 1997-04-30 | 1998-11-12 | Schering Ag | Polymer coated stents, processes for their manufacture and their use for restenosis prophylaxis |
| KR100428634B1 (en) | 1997-07-11 | 2004-11-03 | 주식회사 코오롱 | Method for preparation taxol using fungus showing improved taxol producing activity |
| JPH1192468A (en) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | New taxane derivative |
| AU9596698A (en) | 1997-10-15 | 1999-05-03 | Thomas Jefferson University | Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US20020164374A1 (en) | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
| US6150537A (en) | 1997-12-12 | 2000-11-21 | Emory University | Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
| WO1999055317A2 (en) | 1998-04-30 | 1999-11-04 | The Johns Hopkins University | Treatment of advanced decompensated heart failure with nitric oxide donors |
| PT1082316E (en) | 1998-05-01 | 2004-11-30 | Napro Biotherapeutics Inc | PROCESSES AND INTERMEDIARIES FOR PACLITAXEL SYNTHESIS FROM C-7, C-10-DI-CBZ-BACATIN III |
| US5981564A (en) | 1998-07-01 | 1999-11-09 | Universite Laval | Water-soluble derivatives of paclitaxel, method for producing same and uses thereof |
| US5916913A (en) | 1998-08-03 | 1999-06-29 | Joseph; Hazel L. | Inhibition of wound contraction with paclitaxel, colchicine and penicillamine |
| ES2179526T3 (en) | 1998-08-21 | 2003-01-16 | Pharmachemie Bv | ANALOGS AND PROFARMACOS OF PACLITAXEL SOLUBLES IN WATER. |
| US6017948A (en) | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| US6071952A (en) | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| IT1311923B1 (en) | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
| IT1311921B1 (en) | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
| IT1311924B1 (en) | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
| WO2001010344A1 (en) | 1999-08-04 | 2001-02-15 | C.R. Bard, Inc. | Nitric oxide releasing medical devices |
| IT1314184B1 (en) | 1999-08-12 | 2002-12-06 | Nicox Sa | PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF STRESS-OXIDATIVE CONDITIONS |
-
2001
- 2001-06-22 CA CA002410632A patent/CA2410632A1/en not_active Abandoned
- 2001-06-22 WO PCT/US2001/019939 patent/WO2001098286A1/en active IP Right Grant
- 2001-06-22 EP EP01948610A patent/EP1301500B1/en not_active Expired - Lifetime
- 2001-06-22 JP JP2002504242A patent/JP2004501143A/en active Pending
- 2001-06-22 US US09/886,494 patent/US6656966B2/en not_active Expired - Fee Related
- 2001-06-22 DE DE60131537T patent/DE60131537T2/en not_active Expired - Fee Related
- 2001-06-22 AU AU7007001A patent/AU7007001A/en active Pending
- 2001-06-22 AU AU2001270070A patent/AU2001270070B2/en not_active Ceased
-
2003
- 2003-10-14 US US10/682,923 patent/US6869973B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001270070A1 (en) | Nitrosated and nitrosylated taxanes, compositions and methods of use | |
| AU7007001A (en) | Nitrosated and nitrosylated taxanes, compositions and methods of use | |
| IL150368A0 (en) | Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use | |
| AU2003293529A1 (en) | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use | |
| AU2003291668A1 (en) | Sacrificial compositions, methods of use thereof, and methods of decomposition thereof | |
| AU4841700A (en) | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use | |
| AU2002357119A1 (en) | Mitocidal compositions and methods | |
| AU2001281989A1 (en) | Novel heteroaryl derivatives and use thereof as anti-tumour agents | |
| AU2003259735A1 (en) | Small-mer compositions and methods of use | |
| AU3713600A (en) | Nitrosated and nitrosylated prostaglandins, compositions and metods of use | |
| AU2003299441A1 (en) | Nf-hev compositions and methods of use | |
| AU2001261194A1 (en) | Novel members of the lysyl oxidases family of amine oxidases related applications | |
| AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
| AU2002251140A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2756301A (en) | Compositions comprising genome segments and methods of using the same | |
| AUPR446801A0 (en) | Novel compositions and uses therefor | |
| AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
| AU2002361023A1 (en) | Stabilizer composition, production and use thereof | |
| AU2001238091A1 (en) | Tgf-beta therapeutics, compositions and methods of use | |
| AU2002359869A1 (en) | Pak5-related compositions and methods | |
| AU2003238034A1 (en) | Novel use of imidazotriazinones | |
| AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
| AU2002229859A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2002319505A1 (en) | Hair extension kits | |
| AU2001249940A1 (en) | Aminoflavone compounds, compositions, and methods of use thereof |